Evidence map›Paper›PMID 32165488›Full record

ArticleHaematologica2021

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation.

Burak Kalin, Elisabetta Metafuni, Mariëtte Ter Borg, Rebecca Wijers, Eric Braakman, Cor H J Lamers, Andrea Bacigalupo, Jan J Cornelissen

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Burak KalinErasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Elisabetta MetafuniIstituto di Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.
Mariëtte Ter BorgErasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Rebecca WijersDept. of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC, Rotterdam, the Netherlands.
Eric BraakmanErasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Cor H J LamersDept. of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC, Rotterdam, the Netherlands.
Andrea BacigalupoIstituto di Ematologia, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy.
Jan J CornelissenErasmus University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Erasmus MC · NLIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationCD4-Positive T-LymphocytesHumansTransplantation Conditioning

Identifiers

PMID32165488
PMCPMC7849555
OpenAlexW3011795970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.